Novo A/S »

Lanzatech Global shares owned by Novo A/S

Quarter-by-quarter ownership of Lanzatech Global (LNZA) shares owned by Novo A/S from 13F filings

Historical chart of Novo A/S investment in Lanzatech Global

Tip: Access up to 7 years of quarterly data

All positions including Lanzatech Global held by Novo A/S consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Lanzatech Global by Novo A/S

Quarter filed Position value Share count Share price at filing
2025-12-31 $2.2M 158k 13.76
2025-09-30 $3.9M 158k 24.51

More positions owned by Novo A/S

Brookfield Corp Cl A Ltd Vt Sh (BN)
Edgewise Therapeutics (EWTX)
Asml Holding N V N Y Registry Shs (ASML)
Mirum Pharmaceuticals (MIRM)
salesforce (CRM)
Crinetics Pharmaceuticals In (CRNX)
Miragen Therapeutics (VRDN)
Maplight Therapeutics (MPLT)
Zenas Biopharma (ZBIO)
Pharvaris N V (PHVS)
Apogee Therapeutics (APGE)
Vaxcyte (PCVX)
BioMarin Pharmaceutical (BMRN)
Arrivent Biopharma (AVBP)
Alibaba Group Hldg Sponsored Ads (BABA)

View all positions for Novo A/S

Top funds holding Lanzatech Global

Novo A/S
Vanguard Group
Millennium Management
Geode Capital Management
DRW Holdings
BlackRock
SBI Securities
UBS Group
Royal Bank of Canada
Group One Trading
Jones Financial Companies, L.L
FMR
Tower Research Capital
Farther Finance Advisors
Bnp Paribas Arbitrage, Snc

View all funds holding Lanzatech Global